Trial Profile
An Open Label, Single-Period, Phase 1 Study To Evaluate The Pharmacokinetics, Excretion, Mass Balance And Metabolism Of [14c]-PF-04991532 In Healthy Adult Male Subjects.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 22 Dec 2011
Price :
$35
*
At a glance
- Drugs PF 4991532 (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- 16 Dec 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 09 Dec 2011 Planned end date changed from 30 Nov 2011 to 1 Dec 2011 as reported by ClinicalTrials.gov.
- 09 Dec 2011 Status changed from not yet recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.